The province of British Columbia can bring a class action lawsuit against pharmaceutical companies for opioid harms on behalf of multiple governments across Canada, the country’s Supreme Court ruled on Friday.
In 2018, BC sued more than 40 drug manufacturers, wholesalers and distributors, alleging they fueled the harms of the opioid epidemic by deceptively underplaying the drugs’ dangers in their marketing.
BC was challenged by some companies when it tried to bring a class action on behalf of other Canadian federal, provincial and territorial governments and agencies that pay for care and treatment related to the opioid crisis.
The appeal by Sanis Health Inc., Shoppers Drug Mart Inc., Sandoz Canada Inc. and McKesson Canada Corp. was dismissed Friday by the Supreme Court of Canada, deeming BC’s ability to bring a class action constitutional.
The original BC civil claim was brought against companies including Apotex Inc., Bristol-Myers Squibb Co, Johnson & Johnson, Purdue Pharma LP, Teva Pharmaceutical Industries Ltd. and Loblaw Cos. Ltd. A claim against Purdue was settled for C$150 million ($107 million) in 2022.
Photograph: British Columbia was challenged by some companies when it tried to bring a class action on behalf of other Canadian federal, provincial and territorial governments and agencies. Photo credit: Eric Baradat/AFP/Getty Images
Was this article valuable?
Here are more articles you may enjoy.
AI Needs Its Own Risk Class: Lockton Re 
Insurance Broker Stocks Sink as AI App Sparks Disruption Fears 
Munich Re Unit to Cut 1,000 Positions as AI Takes Over Jobs 
Judge Tosses Buffalo Wild Wings Lawsuit That Has ‘No Meat on Its Bones’ 
